B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Elutia, Inc. - Class A Common Stock (NQ:ELUT)

0.7999 +0.0230 (+2.96%)
Delayed Quote Updated: 12:22 PM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elutia, Inc. - Class A Common Stock

< Previous 1 2 Next >
News headline image
Elutia (ELUT) Q2 2026 Earnings Call Transcript ↗
CEO Mills reports 96% surgeon interest in NXT-41x platform ahead of late 2026 FDA clearance. 
Via The Motley Fool
Topics Earnings
News headline image
Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.
Acquisition expands Cellution Biologics’ human tissue-based portfolio and marks its entry into the U.S. reconstructive surgery market 
From Cellution Biologics
Via GlobeNewswire
News headline image
Elutia Q2 2026 Earnings Call Transcript ↗
On Thursday, Elutia (NASDAQ:ELUT) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For... 
Via Benzinga
Topics Earnings
News headline image
Elutia Sheds Legacy Business to Chase $1.5 Billion Market Opportunity ↗
Elutia (NASDAQ:ELUT) sells SimpliDerm to Cellution Biologics for up to $11M to boost its balance sheet ahead of the NXT-41x launch. 
Via Benzinga
Elutia Inc (NASDAQ:ELUT) Reports Q4 Revenue Miss Amid Key FDA Submission for NXT-41 ↗
Via Chartmill
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 14, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching
Issued on behalf of Conexeu Sciences Inc. 
From World Street Intelligence
Via GlobeNewswire
News headline image
Elutia (ELUT) Q1 2026 Earnings Transcript ↗
Elutia (ELUT) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
SWK Holdings Provides Portfolio Update
Via ACCESSWIRE
News headline image
Recap: Elutia Q4 Earnings ↗
 
Via Benzinga
News headline image
Elutia (ELUT) Q4 2025 Earnings Call Transcript ↗
Elutia (ELUT) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
These stocks that are showing activity before the opening bell on Friday. ↗
Wondering what's happening in Friday's pre-market session? Find an overview in this article. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers SciSparc (NASDAQ: SPRC) shares increased by 28.2% to $5.68 during Monday's after-market session. The company's market cap stands at $2.2 million. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Elutia (ELUT) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Lawsuit
News headline image
Elutia Posts Narrower Loss in Fiscal Q2 ↗
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
ELUT Stock Earnings: Elutia Misses EPS, Misses Revenue for Q2 2024 ↗
ELUT stock results show that Elutia missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
Via ACCESSWIRE
News headline image
7 Growth Stocks to Buy for Under $5 for Massive Gains ↗
Although growth stocks under $5 are inherently risky and unpredictable, their very nature also facilitates robust upside potential. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 14, 2024 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
ELUT Stock Earnings: Elutia Misses EPS, Beats Revenue for Q1 2024 ↗
ELUT stock results show that Elutia missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
ELUT Stock Earnings: Elutia Misses EPS, Misses Revenue for Q4 2023 ↗
ELUT stock results show that Elutia missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.